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       This evidence-based clinical change project addressed the clinical problem trigger of 
increased rates of urinary tract infections and related unplanned discharges in a rural 
Ohio nursing center. The clinical change involved the implementation of a nursing-driven 
protocol for suspected Urinary Tract Infection (sUTI) based on the American Medical 
Director’s Association Clinical Practice Guideline: Common Infections. An 
interdisciplinary team approach to evidence-based clinical change was utilized through 
use of the Iowa Model of Evidence-based Practice to Promote Quality Care.  Both the 
process and the intervention were evaluated through analysis of outcome data including 
rates of urinary tract infection, compliance with the guideline recommendations, 
measurement of adverse outcomes, and evaluation of policy. The sUTI protocol was 
piloted for a three-month period and outcomes included a reduction in incidence of UTI 
from 5.4 to 3.8 infections per 1000 resident days and statistically significant 
improvements in center compliance with clinical practice guidelines for recognition and 
management of suspected UTI.  The analysis of cost, benefits, and sustainability of this 
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I.  INTRODUCTION 
 
       Infections are a significant source of illness and death in the long-term care (LTC) 
setting. Infections account for about 25% of hospital admissions from LTC nursing 
centers and the incidence of infectious diseases in nursing centers is on the rise (Vance, 
2001).  By 2030 the number of older adults in the United States (U.S.) is projected to 
reach 71.5 million, representing approximately 20% of the national population (Federal 
Interagency Forum on Aging-related Statistics, 2008).  The 2004 National Nursing Home 
Survey found 1.5 million residents living in 16, 628 nursing homes across the U.S.; 
88.3% of them are older adults (U.S. Department of Health and Human Services, 2009).  
Although only around 4% of the U.S. population lives in a nursing home at any given 
moment, it has been estimated that greater than 40% of the older adult population in our 
country will spend some time in a nursing home during their lifetime.  The risk of 
Healthcare Associated Infections (HAI) in LTC is reported to range from 1.8- 13.5 
infections per 1000 resident-care days (Strausbaugh & Joseph, 2000).  In light of the 
current trend toward shorter hospitalizations, longer nursing home stays, and the growth 
of the number of older adults in the U.S. during this century, the likelihood of an 
unprecedented increase in the number of LTC residents at increased risk for morbidity 
and mortality due to infection is high. Important clinical concerns have arisen from these 
trends.  The American Medical Directors Association (AMDA) has developed a clinical 
practice guideline (CPG) for common infections in the LTC setting.  This guideline was 
developed by interdisciplinary workgroups using a process combining evidence and 
consensus-based thinking, and has been reviewed by national organizations and 




published studies of estimated prevalence rates for infections in LTC and the availability 
of clinical guidelines designed for LTC infection control, there are limited data that 
evaluate the effectiveness of these measures.  There is also a lack of evidence pertaining 
to the implementation of such guidelines in LTC. This translates into a heightened need 
for attention in healthcare to the unique contributing and modifying factors for infection 
in this vulnerable population.  This information is particularly pertinent to advanced 
practice registered nurses (APRN’s) working in the LTC setting.  These APRN’s are 
uniquely positioned to potentially impact the integration of evidence-based protocols and 
practices into the LTC setting that have the potential to reduce or eliminate HAI’s in this 
population.  
Clinical Problem 
       The focus of this project was the incidence of and outcomes associated with HAIs of 
the urinary tract in adult residents of a long-term care (LTC) facility.  This focus was 
driven by a noted increase in UTI ‘s in center residents and unplanned discharges of 
residents from the LTC center to acute care facilities with diagnoses of urinary tract 
infection (UTI) (Figure 1). These unplanned transfers/discharges were a source of 
concern as the result was a loss of revenue for the center.  A cohort study by Grenier, 
Bell, Bronskill, Schull, Anderson, and Rochon (2010) suggested that UTI is responsible 
for almost 25% of the visits made to emergency departments by LTC residents. 
       Quality indicators were also impacted by these trends in regard to number of 
infections and decline in function.  Infections are very common in the LTC setting, 
represent a major source of morbidity and mortality in LTC, and UTIs are one of the 




Jans, & Buntix, 2007; Smith et al., 2008).  Prevalence of urinary tract infections, a quality 
indicator, was analyzed for the center.  The data was collected from the Mini Data Set 
(MDS) system and UTI was defined as it is reported into the MDS system. For the 
purposes of reporting, UTI is defined as signs and symptoms of UTI (i.e. dysuria, fever, 
urinary frequency, new/increased urinary incontinence) and a urine culture with 
microorganisms reported at greater than or equal to 100,000 cfu/ml or a documented 
diagnosis of UTI by a medical provider. This analysis confirmed that the rate of 
infections was on the rise in the center and was significantly higher than the national and 
state percentages (Figure 1).   The December 2011 UTI incidence in the center was nearly 
twice that of the national percentage.  The incidence of UTI in the center had improved 
marginally since that time but remained a concern for the facility from a quality 
perspective. 
























Purpose and Goals of Project 
       The overall project goal was to improve the quality of care of LTC residents through 
use of best practices for the prevention and management of UTI.  The project had several 
objectives including: 1) evaluate gaps between current center practices and the AMDA 
Clinical Practice Guideline: Common Infections (AMDA CPG: CI)  2) design approaches 
to assist the LTC center integrate the evidence into practice, 3) implement the 
approaches, 4) evaluate the outcomes (UTI rates, antimicrobial usage and adverse 
outcomes), and 5) evaluate the process of systematic implementation of the AMDA CPG: 
CI recommendations for reduction and appropriate management of UTI.  
        In evidence-based practice (EBP), clinical questions are asked in PICOT format. 
PICOT is an acronym used to represent Patient population, Issue of interest, Comparison 
intervention, Outcome, and Time frame. PICOT format assists the investigators to search 
for and retrieve the most relevant and best evidence (Melnyk & Fineout-Overholt, 2011). 
This Doctorate of Nursing Practice (DNP) EBP clinical change project PICOT question 
was: In patients living in a LTC facility (P), how does implementation of the AMDA 
Clinical Guideline: Common Infections (AMDA CPG: CI) (I) compared to current 
practices(C) affect urinary tract infection rates, antimicrobial usage, unplanned 
discharges (O) over three months (T).   
Evidence-based Practice Model 
      The Iowa Model of Evidence-based Practice to Promote Quality Care is the EBP 
model that was used for the project.  The Iowa Model is a seven-step process that focuses 
on organization and collaboration to incorporate research and other types of evidence into 




continually cited in nursing journals and extensively utilized in clinical research 
programs (LoBiondo-Wood and Haber, 2006).  The Iowa Model employs a linear design 
with multiple “feedback loops” that facilitate fluid movement through the evidence-based 
process with analysis and evaluation at each step (Titler et al., 2001).  A factor that 
illustrates the goodness of fit for the Iowa Model to this project is the concept that not 
only evidence from the literature, but also internal evidence from the organization is 
integrated (Titler et al., 2001). Table 1 displays the seven steps of the Iowa Model as 
applied to the project. 
Table 1: Application of the IOWA Model to the EBP Project 
Steps of the Iowa Model  Proposed Project Application 
 
STEP 1 
Selection of a Topic 
Trigger of increased unplanned discharges from center to acute care 
with diagnoses of infection was noted (UTI was most common). 
Director of Nursing and Director of Clinical Services and APRN met 
to analyze center quality indicators. A combination of data from the 
MDS and chart reviews were utilized. UTI in the facility was noted to 
be increasing over past months. 
Topic of “Reducing UTI’s in the center and improving outcomes” 
was determined  
This clinical problem was accepted as having high organizational 
priority related to the impact on quality and financial aspects in the 
center. 
 
STEP 2  
Forming a Team 
The interdisciplinary team members will include: 
APRN- project leader 
Director of Nursing 
Assistant Director of Nursing 




The APRN led this step. The current evidence was searched and 
retrieved. Databases searched included: CINAHL, PubMed, 
Cochrane Database of Systematic Reviews. 
STEP 4 
Grading the Evidence 
The APRN lead this step.  
See Evaluation and Synthesis Tables 
Step 5 
Developing an EBP 
Standard 
The APRN presented the results of the search Strategy and Synthesis 
to the team members at the center’s monthly Quality Meeting.  




be the most applicable for the center in regard to appropriateness, 
feasibility, meaningfulness and effectiveness.  
The team developed a plan, timeline and process for implementation 
of the standard.  
Step 6 
Implementing EBP 
Pilot site for the project was selected. 
Review of current policies, procedures in comparison to AMDA 
CPG:CI completed.  
Baseline UTI rates in the center were identified.  
Baseline antibiotic usage in the center was identified.  
Retrospective chart reviews were completed on resident records to 
analyze the current practices in comparison to the AMDA Guideline.  
sUTI Worksheet was developed for integration of the AMDA CPG: 
CI. 
Education of staff/clinicians completed regarding the 
guideline/intervention/processes.  
Step 7 
Evaluation of the 
Change 
A retrospective chart review of resident records was completed 3 
months following full implementation of the intervention to evaluate 
compliance with the guideline and determine outcome data. 
Incidence of UTI, antibiotic usage, and unplanned discharges were 
compared to the baseline.    
 
       The Iowa model also emphasizes problem solving and is “widely recognized for its 
applicability and ease of use by multi-disciplinary healthcare teams” (Melnyk & Fineout-
Overholt, 2011, p.251).   This was a major consideration in the selection of the Iowa 
Model as the project utilized a multi-disciplinary team approach involving nursing, 
medicine, administration, and pharmacy.     
 The EBP Clinical Change Project 
        The setting for the clinical change project pilot was a 98-bed, for-profit, 
Medicare/Medicaid certified extended care nursing center in rural southwest Ohio. The 
seven steps of the Iowa Model served as the guiding framework for organizing the project 
from planning through evaluation. The Iowa Model employs a linear process design but 
emphasizes fluid movement within the process based on evaluation at each step (Titler et 





Iowa Model Step 1: Selection of a Topic 
        The first step in the Iowa Model is selection of a topic with emphasis on 
identification of a problem- focused trigger. The problem-based trigger for this project 
was presented in the introduction with the statement of the clinical problem and PICOT 
question. The Iowa Model identifies the importance of ascertaining that the clinical 
problem being addressed is an organizational priority in order to facilitate cooperation 
and support for the project.  The problem identified for this project had clearly been 
accepted as an organizational priority as it stood to impact both the financial and quality 
aspects of the center. In the LTC setting, the key stakeholders encompass the 
organization’s hierarchy including: corporate leaders, center administration, medical 
providers, nurse supervisors, all front line and ancillary staff, patients and families.   
 Iowa Model Step 2: Forming a Team 
        The second step in the Iowa Model is selection of a team. As part of the project 
development, this DNP student, as project leader, met with the center administration and 
solicited suggestions for the EBP Project Team membership. Upon consideration of those 
recommendations and the need to involve members from multiple disciplines, the EBP 
team will be comprised of the following members: 
• APRN- the Doctorate of Nursing Practice (DNP) student was an APRN and 
served as team leader for the EBP Practice Change Team.  The role of the APRN 
was to lead the EBP process and report to stakeholders as necessary to gain 
support/resources, educate the team members on the Iowa Model and the EBP 




• Director of Nursing (DON) - this individual’s support of the clinical project was 
essential as the role and responsibility of the DON is for day-to-day operations of 
the nursing department and review of policy.  DON buy-in to the project was a 
critical first step in the implementation process.  The DON role on the committee 
was to provide guidance on data sources and retrieval, input on policy review and 
revision, and leadership for the marketing of the project.   
• Assistant Director of Nursing (ADON) - this individual was involved in both the 
planning and implementation phases of the project as the CSD oversees the 
infection surveillance activities, the immunization program and facilitates the 
clinical education and in -servicing. 
• Medical Director- this individual drove the acceptance of the guideline by center 
clinicians, participated in review/revision of current policy, and served as a key 
advisor in development of the protocol.  
• Pharmacist Consultant- this individual will provide expertise for the analysis of 
antibiotic usage and concerns related to the project.  
        As part of the project pilot development, an initial meeting of the EBP Project Team 
was held and the APRN introduced the problem-based trigger, the PICOT question, and 
the preliminary literature review findings. The AMDA CPG: CI was discussed and 
determined by the team to be the most applicable for the center in regard to 
appropriateness, feasibility, meaningfulness and effectiveness. The resources necessary 
for implementation were discussed and determined to be feasible. The team accepted the 
PICOT question as proposed and acknowledged the role that each member will fulfill as 




has been fragmented and difficult to evaluate. Gaining support and buy-in for this EBP 
project from those involved in the performance improvement was essential for success of 
the project. Anticipated barriers to implementation of this clinical change project 
identified by the EBP Project Team included: 
• Need for staff buy-in and accountability for utilizing the EBP project process. 
• Sustainability of the guideline across shifts and over time. 
• Acceptance of and compliance with guideline recommendations by all facility 
medical providers. 
• Lack of history of culture in support of EBP within the center.  
• Historical limited engagement by professional pharmacy and medical 
professionals in quality improvement activities in the center.  
 The anticipated barriers were addressed through frequent communication from the 
project team to staff and stakeholders. The center in which the pilot was completed is part 
of a large corporation with sizable clinical resources available. Anticipated Facilitators of 
the clinical change project identified by the EBP Project Team included: 
• Support from the DON, center Administrator, and nursing leadership with the 
clinical problem identified as an organizational priority. 
• Administrator support for compensation of staff/team members for team meeting 
times and educational time.  
• Medical Director support of the project. 
Appendix A contains the barriers and the specific strategies utilized for addressing these 
as well as the facilitators and the strategies employed to sustain them throughout the 




II. LITERATURE SEARCH, APRAISAL, AND ANALYSIS 
        In this section, the clinical literature and clinical practice guidelines relevant to UTI 
in LTC and integration of CPG’s in LTC are reviewed and analyzed.  The seven steps of 
the Iowa model continue to be utilized as an organizing framework. The significance of 
this analysis to the project are discussed and gaps between the existing literature and 
clinical practice are acknowledged.   
Iowa Model Step 3: Evidence Retrieval 
       The literature review is an essential aspect of the Iowa Model. The APRN led the 
retrieval of evidence from electronic databases including: The Cumulative Index of 
Nursing and Allied Health (CINAHL), PubMed (Medline) and the Cochrane Database of 
Systematic Reviews.  The AMDA Guideline: Common Infections was also appraised as 
were several other national guidelines pertaining to UTI prevention. Grey literature was 
avoided in this literature review as adequate research-based articles were identified. 
Studies were identified through a search of the aforementioned databases from 2000 to 
the present using subject headings “urinary tract infection” or “UTI” combined with 
“long term care” or “LTC” with the use of controlled vocabulary through the databases.  
Limits were also set in the PubMed database to include only those articles available in 
English, dated 2000 or more recent, age 19+ years, clinical trial, meta-analysis, practice 
guidelines, and randomized control trials.  This strategy reduced the hits from 28,918 to 
1,033.  Adding an additional limit of evidence-based medicine (EBM) reduced the hits to 
16. Limits were set in the CINAHL database to include articles in English and EBP only.  
This strategy reduced the hits from 2157 to 62.   A search of the CINAHL database for 




hits. The PubMed (Medline) databases was also searched with the terms “clinical practice 
guidelines” and “urinary tract infections” with limits of human, aged 65+ years, and 
English which yielded 47 hits.  The Cochrane database was searched with the keyword 
“urinary tract infection” combined with “older adults” or “long term care” which yielded 
25 hits. The search strategy was repeated September 2013 with additional limits of date 
range December 2012- 2013 to update the original literature search and yielded one 
additional systematic review of infection prevention in LTC.  The final cohort hits were 
reviewed by reading the abstracts and only those articles pertaining specifically to urinary 
tract infection in long term care or the older adult and prevention or reduction of infection 
and having publication dates 2010 or more current will be retained for appraisal from the 
Cochrane, CINAHL and PubMed databases.  The final number of 
articles/studies/guidelines retained for future critical appraisal was 17.  The abstracts 
contained information suggesting that these articles pertain specifically to urinary tract 
infection in long term care and impact on adverse outcomes or rate of infection, or 
implementation of CPGs in LTC. All articles pertaining specifically to the use or 
evaluation of CPG’s in LTC with publication dates in the past 10 years were included.  
No articles were identified that were specific to the PICOT question in regard to 
evaluation of use of the AMDA CPG: CI and impact on UTI rates or outcomes. The 
search strategy and results are summarized and presented in Appendix B. The evidence 







Iowa Model Step 4: Grading and Synthesis of the Evidence 
         This step in the Iowa Model includes the critical appraisal and synthesis of 
evidence. Relevant literature was evaluated and summarized in a table format. Refer to 
Appendix C for this summary of the literature.  Melnyk & Fineout-Overholt’s (2011) 
rating system for the hierarchy of evidence was utilized to grade the evidence. This 
system was adapted from Guyatt and Rennie’s hierarchy and includes seven levels of 
evidence with level one evidence being considered the highest level of evidence and level 
seven being the lowest level of evidence. The evidence was examined and the essential 
elements considered beginning with level I evidence and moving down the hierarchy.  
There is a paucity of existing studies pertaining to the prevention and management of 
UTI specifically in the LTC setting (Uchida, Pogozelska-Maziarz, Smith & Larson, 
2013). This lack of scientific evidence to evaluate recommended interventions is a source 
of much concern and support for the need for nursing research in this area.  
        Three CPGs, which were considered level I evidence based on the strategies used in 
guideline development, were evaluated.  Two of these CPGs were included in the AMDA 
CPG: CI.  The third CPG (HICPAC Guideline for Prevention of CAUTI-2009) was not 
included in the AMDA CPG: CI likely due to it being released after the AMDA guideline 
was developed.  The HICPAC guideline provides a rich source of descriptive grading of 
evidence in support of the included recommendations.  As many of these 
recommendations are included in the AMDA CPG: CI, this new CPG lends further 
support to the AMDA CPG: CI.   The AMDA CPG: CI is derived from evidence-based 
guidelines, current available evidence and expert consensus.  The AMDA CPG: CI was 




the national professional association of medical directors, attending physicians, and 
others practicing in long term care.  The development of the guideline used a process of 
combined evidence and consensus –based approaches.  The process to guideline 
development is described as systematic and including literature review, framework 
development, and interdisciplinary contributions.  AMDA relates the ongoing issue of 
limited scientific evidence in LTC as requiring some recommendations to be based on 
expert consensus. Each recommendation within the guideline is linked with the scientific 
evidence available.  There is, however, a lack of detailed explanation of the quality of 
evidence supporting the recommendations.  The recommendations are clinically relevant 
to the LTC setting, are practical and feasible in the LTC setting, and are in alignment 
with current practice.  The outcomes of the guideline can be measured through standard 
care with analysis of outcomes data from the MDS database, chart reviews, as well as 
other existing center data sources.  The AMDA Clinical Practice Guideline Steering 
Committee reviews the guideline every three years.  The results of the critical appraisal 
of the AMDA CPG: CI and the three other CPG’s are summarized in Appendix D.   
       The scientific evidence pertaining to the implementation and evaluation of CPG for 
UTI prevention in LTC is quite limited.  Much of the literature that relates to this topic 
takes the form of expert opinion or applied research of older adults and geriatric 
medicine.  For the purposes of this literature review, key evidence within the AMDA 
CPG: CI pertaining to UTI was identified and is presented in Appendix C.  The overall 
level of evidence that supports the use of the AMDA CPG: CI is moderate. The AMDA 
CPG: CI is an evidence-based and practice- based guideline consistent with level B 




support recommendations as there is moderate certainty that the benefit of the 
intervention is moderate to substantial and benefits outweigh harms 
(http://www.ahrq.gov/about/evaluations/uspstf/uspstfeval1.htm). The AMDA CPG: CI 
incorporates evidence from the highest level of evidence currently available (CPG’s from 
leading healthcare organizations).  There are elements of the guideline that have high 
quality evidence to support the recommendations but there are also some components that 
are not based on high quality evidence due to the lack of such evidence; in these 
instances, the guideline developers provide expert consensus data to support the 
recommendation.   The AMDA CP G: CI provides a synthesis of the available evidence 
pertaining to the most common infections encountered in LTC. Table 6 displays the 
critical appraisal data for the AMDA CPG: CI, as well as the Infectious Diseases Society 
of America (IDSA) CPG for catheter-associated UTI (2010), and the Society for 
Healthcare Epidemiology of America (SHEA)/Association for Professional in Infection 
Control and Epidemiology (APIC) for infection prevention and control in the long term 
care facility which are included in the AMDA CPG: CI.  Table 6 also includes critical 
appraisal data for the Healthcare Infection Control Practices Advisory Committee 
(HICPAC) of the Centers for Disease Control (CDC) guideline for prevention of catheter-
associated UTI.  These CPG’s represent the highest level of evidence available regarding 
UTI in LTC.  
        The entire AMDA CGP: CI appears to be best implemented utilizing an 
interdisciplinary team approach in the center.  The guideline takes a general approach to 
infection control but also includes specific recommendations for the most common 




evidence into this comprehensive guideline, which contains strategies and considers 
factors that are unique to the LTC setting, was a necessary first step toward facilitating 
higher quality evidence to support these recommendations in the LTC setting.  
       The literature regarding CPG use in LTC is also sparse and limited to small 
retrospective studies and several qualitative studies.  Seven studies pertaining specifically 
to CPG use in LTC were identified and appraised (Appendix E).  Deuster et al. (2010) 
conducted an intervention study to evaluate the use of treatment guidelines to improve 
antibiotic therapy use (N=100) and found that implementation of treatment guidelines 
increased the appropriate antibiotic use in a LTC facility.  A systematic review by 
Flodgren et al. (2013) examined the efficacy of strategies to promote staff adherence to 
infection control measures and in thirteen studies found insufficient evidence to support 
any specific measures changing adherence behaviors. A qualitative study by  Resnick et 
al. (2004) explored the feasibility of implementing CPG’s in LTC settings and resulted in 
four themes being identified: 1) challenges to implementation, 2) benefits of 
implementation, 3) process recommendations, and 4) recommendations for changes to 
CPGs. Another qualitative analysis by Colon-Emeric (2007) identified additional barriers 
to implementation of CPGs in LTC. In a retrospective study, Wipke-Tevis et al. (2004) 
(N=362) revealed that forty percent of LTC facilities were using a tool to assess pressure 
ulcer risk and prevention that was not evidence-based. Hutt et al. (2006) conducted a 
quasi-experimental pre-post test with a control group to assess feasibility of the use of 
evidence-based guidelines for treatment of community-acquired pneumonia in nursing 
homes; findings suggested that compliance with some guideline components improved. 




being used in nursing homes (N=1065) and found that less than fifty present reported 
adoption and use of CPGs.   
        Analysis of the literature indicates that although CPG’s applicable to LTC are 
available, the actual systematic implementation of CPG’s in this setting remains poor 
(Berlowitz, et al., 2001; Colon-Emeric, et al., 2007; Resnick, Quinn, & Baxter, 2004).  
Several studies have indicated that the potential for CPG’s to improve quality and 
compliance with current practice standards is good (Deuster, Roten, & Muehlebach, 
2010; Hutt, et al., 2006).  Results of qualitative studies have supported the feasibility of 
the use of CPG’s in LTC as a means of quality improvement in regard to improvement in 
documentation and outcomes (Colon-Emeric et al., 2007; Resnick et al., 2004).  
Qualitative data also provided some perceptions regarding barriers to the implementation 
of CPG’s including perceived lack of congruence between the guidelines and the 
patient/family wishes, lack of congruence of guidelines with current policies, perception 
of guidelines as inhibiting individualized care, getting staff buy in, dealing with issues of 
staff turnover and sustaining implementation as new staff replace old, and ensuring 
accountability of nursing staff to promote the use of the guidelines(Resnick et al.,2004; 
Colon-Emeric et al., 2007).  The same studies also identified some potential facilitators of 
implementation of CPG’s in the LTC setting which included streamlining the guidelines 
into algorithms, incorporating the guideline recommendations into standing orders, 
implementing one CPG at a time, designating a person or small team to champion the 
implementation of the guideline, developing tools for each guideline, and involving staff 
in a stepwise education process for implementation (Colon-Emeric et al., 2007; Resnick 




synthesize the most current and quality evidence and expert opinion into best practice 
standards (Institute of Medicine, 2000).  A single systematic review assessed the efficacy 
of interventions which target healthcare professionals or organizations to improve 
professional adherence to infection control guidelines on device-related infection rates 
and suggested that educational interventions with multiple active elements that are 
administered repeatedly over time are most effective (Flodgren et al., 2013).  An 
intervention study measuring effectiveness of incorporating a practice algorithm for 
suspected UTI in LTC patients resulted in a UTI rate reduction by 30% and antibiotic 
usage reduction of 20%, which persisted over twelve months (Genao & Buhr, 2012). 
Similarly, another intervention study utilizing an educational intervention noted sustained 
reductions in inappropriate treatment of asymptomatic bacteriuria in a LTC center 
(Zabarsky, Sethi, & Donskey, 2008).  An increasing number of CPG’s have been 
developed specifically for use in LTC. The AMDA has led the way of this trend with 
evidence-based CPG’s that take into account many of the factors unique to the LTC 
environment.  The existing literature provides some important considerations in quality 
improvement intervention development. The pertinent literature from 2010 (the last 
publication date included in the AMDA CPG: CI) to the present was evaluated and is 
presented in Appendix F.  Further discussion of the literature is included in Step 5 with 
the recommendations for practice change.   
Iowa Model Step 5: Developing an EBP Standard 
Recommendations for Practice Change 
        This step of the Iowa Model involves establishing recommendations for practice 




significant source of morbidity and mortality in the LTC setting (Tsan, et al., 2010). The 
AMDA, the premier professional association for LTC clinicians, has developed a clinical 
guideline for the four most common infections in the LTC setting (respiratory, urinary, 
gastrointestinal, and skin/skin structure).  This guideline was developed by 
interdisciplinary workgroups using a process combining evidence and consensus-based 
thinking, and has been reviewed by national organizations and individual experts 
(AMDA, http://www.amda.com/tools/guidelines.cfm). The practice recommendation was 
the systematic implementation of the AMDA CPG: CI to address the PICOT question. 
This CPG represents the highest available evidence for prevention and management of 
UTI in the LTC setting as it is a CPG based on systematic review of available evidence 
(AMDA, 2011).   The clinical change  project intervention was an evidence-based and 
practice- based guideline consistent with Level B utilizing the USPSTF system for 
evaluating evidence to support recommendations as there is moderate certainty that the 
benefit of the intervention is moderate to substantial (U.S. Department of Health and 
Human Services, 2012).  There is a noted lack of evidence in the literature that evaluates 
the use of CPGs in LTC in regard to impact on outcomes.  The project integrated the 
most current practice standards and best practices for infection prevention, recognition, 






III.  IMPLEMENTATION 
        In this section the project implementation is described. The specific practice 
recommendations with rationale from the body of evidence are presented within the 
framework of the twelve steps of the AMDA CPG: CI and are summarized in Table 2.  
Specific elements relative to the project interventions are also discussed here.  
Table 2: Summary of Recommendation for Practice Change 
PICOT Question In patients living in a LTC facility (P), how does 
implementation of the AMDA Clinical Guideline: Common 
Infections (AMDA CPG: CI) (I) compared to current 
practices(C) affect urinary tract infection rates, antimicrobial 




Systematic implementation of the AMDA Clinical Guideline: 
Common Infections including: 
1. Establish protocol for initial nursing assessment/evaluation 
of suspected UTI 
2. Establish protocol for appropriate laboratory test 
evaluation of suspected UTI 
3. Establish protocol for evaluation of need for transfer to 
acute care facility 
4. Establish protocol for implementation of appropriate 
transmission precautions 
5. Establish process for ongoing monitoring and 
documentation of patient response to treatment for 
infection.  
6. Implement an immunization program for all center patients 
7. Implement a center-wide infection control program that 
conforms to federal and state regulations and current 
standards of practice.  
8. Monitor management of infections in the center.  
9. Monitor antibiotic use in the center. 
Level of 
Effectiveness 
The project intervention is an evidence-based and practice- based 
guideline consistent with level B utilizing the USPSTF system for 
evaluating evidence to support recommendations as there is 






This CPG represents the highest available evidence for prevention 
and management of UTI in the LTC setting as it is a CPG based on 
systematic review of available evidence and expert consensus in 




AMDA CPG: CI Step 1: Recognition 
         In this step the guideline emphasizes the importance of prompt recognition of signs 
and symptoms consistent with infection.  This step includes evaluation of vital signs, 
mental status compared to baseline, and the importance of nursing staff reporting these 
acute changes of conditions to healthcare providers. The evidence supports that 
infections, including UTI’s, in LTC residents predispose to serious consequences such as 
dehydration, delirium, falls, sepsis, hospitalization, and even death (Engelhart, Hanses-
Derendorf, Exner, & Kramer, 2005; Mylotte, 2005). In the LTC population UTI’s 
account for approximately one fourth of all infections (Foxman, 2002; Ruben et al., 
1995).  UTI’s have also been estimated to account for up to sixty percent of systemic 
antimicrobials used in the LTC setting (Nicolle, 2001; Nicolle, 2003). UTI’s that are not 
recognized and managed appropriately may also lead to the need for hospitalization of 
LTC residents that can cause disruptions in care, “discomfort and anxiety for residents 
and families, iatrogenic complications during hospitalization with related morbidity, and 
excess health care costs” (Ouslander et al., 2009, p. 645). The project team developed a 
suspected UTI (sUTI) worksheet to be utilized by center nursing staff when a patient is 
suspected of having a UTI (Appendix J). The sUTI worksheet was developed from the 
AMDA CPG: CI and included criteria for change in patient condition that suggests UTI.  
Staff used these criteria to determine when further assessment for sUTI was warranted.  
AMDA CPG: CI Step 2- 4: Assessment 
       In these steps the guideline emphasizes the performance of a targeted history and 
physical exam that aligns with the likely sources of infection based on presenting 




the guideline suggests the use of clinical signs and symptoms to guide the judicious use 
of urinalysis and culture.  This is further supported by the 2009 study by Juthani-Mehta et 
al. in which clinical features associated with bacteriuria plus pyuria (the proposed clinical 
definition for UTI) were found to be dysuria, change in character of urine, and change in 
mental status.  This study further supports the recommendation of the AMDA CPG: CI 
for assessment and reporting of clinical features suggestive of UTI promptly to providers 
so that a clinical decision can be made.  The guideline suggests that positive urine 
dipstick or presence of leukocyte esterase on urinalysis suggest that a urine culture should 
be performed.  Furthermore, the guideline recommends avoiding follow up urine culture 
after antibiotic treatment due to the high incidence of asymptomatic bacteriuria in the 
LTC population. Asymptomatic bacteriuria is prevalent in the LTC population and 
several randomized clinical trials among LTC residents have demonstrated that treatment 
of AB is not beneficial (Abrutyn et al., 1994; Nicolle, Mayhew, & Bryan, 1987; Nicolle, 
Bjornson, & Harding 2000).  Despite the recommendations that treatment of AB with 
antimicrobials be avoided in LTC, the practice remains common in this setting (Loeb et 
al., 2001). An intervention study in an Ohio LTC facility involving an educational 
intervention demonstrated sustained reduction in inappropriate treatment of 
asymptomatic bacteriuria as well as decreased overall antimicrobial use (Zabarsky, et al., 
2008). Genao and Buhr (2012) reported a thirty percent decrease in suspected UTI and 
twenty percent decrease in antibiotic usage over a three-month period with the use of a 
nursing-driven algorithm for suspected UTI management. 
        Inappropriate treatment of AB with antimicrobials results in adverse drug events, 




et al., 1994; Nicolle, 2001, Nicolle, 2003; Ouslander et al., 2009).  Infections with 
MDRO’s have long-reaching consequences for the health of LTC residents and the 
general public. Morbidity associated with infection with MDRO’s leads to increased 
costs associated with increased hospitalizations, treatment, and implementation of 
infection control measures (Straussbaugh, Crossley, Nurse, & Thrupp, 1996).  MDRO 
infections may also contribute to a lower health-related quality of life and functional 
decline (Loeb et al., 2001).  
         Assessment also includes determining whether a patient’s condition requires 
transfer to an emergency department or hospital setting when the patient has unstable 
vital signs, diagnostic tests are not available in the center, or the scope of monitoring or 
treatment exceeds the capabilities of the center.  The assessment component also 
addresses the need for assessment of LTC patients for appropriate use of indwelling 
urinary devices.  The AMDA CPG: CI incorporates recommendations from the IDSA 
CPG for catheter-associated UTI (2010), and the SHEA/APIC guideline for infection 
prevention and control in the long term care facility.  The new HICPAC of the CDC 
guideline for prevention of catheter-associated UTI provides additional support for these 
recommendations for evaluation of appropriate short and long-term catheter use, catheter 
management strategies, and diagnostic criteria for UTI in the LTC setting. An 
intervention study reported that the use of a nursing-driven algorithm for determining 
appropriateness of indwelling urinary catheter placement reduced total catheter days by 
twenty percent (Magers, 2013). The HICPAC CPG sets a new standard for 
documentation of grade of evidence to support recommendations with comprehensive 




the determination of the need for heightened infection control precautions.  Specific to 
UTI this may include the containment of urine that is potentially contaminated by multi-
drug resistant organisms (MDROs).  Standard precautions are those applied at all times to 
all patients and transmission precautions are those that should be implemented in the case 
of known or suspected transmissible diseases.   
        The sUTI worksheet delineated the pertinent history and physical exam elements 
from the AMDA CPG: CI . These elements included vital signs, mental status, and 
urinary symptoms. The worksheet also provided the criteria for laboratory urinalysis and 
culture and implementation of appropriate transmission precautions.  
AMDA CPG: CI Step 5 and 6: Treatment 
       These steps of the guideline focus on the targeted treatment of the symptoms of 
infection through use of supportive measures for comfort (i.e. treatment of fever, 
maintenance of fluid intake, monitor nutritional status and initiate nutritional 
interventions as needed).  The treatment component of the guideline also addresses 
antibiotic therapy.  The guideline suggests that empiric therapy based on center 
epidemiologic data and the most likely source of infection may be warranted but stresses 
the importance of specific therapy through culture when possible.  The guideline refers to 
current CPGs for CAUTI in regard to limiting duration of antibiotic therapy for UTI.  
Deuster et al. (2009) further support the AMDA CPG: CI recommendation for referral to 
targeted antibiotic treatment guidelines to support the judicious use of antibiotics in LTC. 
The sUTI worksheet prompted staff to determine whether the patient met AMDA CPG: 
CI criteria for empiric treatment with an antibiotic and to communicate this to the 




AMDA CPG: CI Step 7-12: Monitoring 
       The monitoring component of the guideline refers to monitoring of: 1) Patient 
response to treatment, 2) monitoring for, identifying and containing identified outbreaks 
of infection, 3) implementing and monitoring an immunization program for patients, 4) 
implementation of a facility-wide program of infection prevention and control that 
complies with both state and federal LTC regulations as well as current practice 
standards, 5) monitoring of infection management in the center, and 6) implementing an 
antibiotic stewardship program in the center. Specific to UTI these guidelines can be 
interpreted to include the need for monitoring of response to antibiotic therapy including 
assessing for recurrent infections and appropriate referral for urologic evaluation when 
warranted.  It suggests that a comprehensive program of infection prevention and control 
including staff education of aseptic catheterization and urine specimen collection 
techniques be implemented.  Perhaps most importantly, the guideline suggests a program 
of monitoring infection trends in the center and participating in antibiotic stewardship 
through evaluation of appropriate antibiotic prescribing and appropriate follow up with 
providers.  
Iowa Model Step 6: Implementing EBP 
        The project was submitted for expedited review through the Wright State University 
Institutional Review Board. The project was determined to be exempt from Institutional 
Review Board approval. Project implementation included three phases.  Each phase is 
presented in the following sections. Appendix H contains an outline for the project 




  Implementation phase I. 
       The EBP Project Team determined the specific project implementation timeline and 
communicated this to key stakeholders via a brief presentation.  The EBP Project Team 
reviewed current policies and procedures in comparison to AMDA CPG: CI for infection 
control measures, immunization program, and infection and antimicrobial surveillance. It 
was determined that current policies and procedures regarding immunization and 
infection control were in compliance with the AMDA CPG: CI. It was also determined 
that the antibiotic surveillance elements of the guideline were also being partially 
followed. The pharmacy and laboratory provided the appropriate antibiotic usage and 
aggregate microbe reports but these were not being shared routinely with providers. The 
ADON added the monthly antibiotic and microbe reports to the agenda for the routine 
Quality Committee meetings to close this gap. Baseline data for the outcome indicators 
were assessed and recorded by the EBP Project Team through retrospective chart audits 
(Appendix I). The MDS and resident chart reviews were the sources of data at both pre-
intervention and post-intervention. Charts were reviewed for treatment of asymptomatic 
bacteriuria and appropriate implementation of transmission precautions in residents 
identified as having been treated for UTI in the center. Retrospective chart reviews were 
completed on records of residents identified as having been treated for UTI in the three 
months pre-intervention to analyze the center practices in comparison to the AMDA CPG: 
CI.  
       Implementation phase II. 
       The EBP Project Team analyzed results of this assessment and determined that an 




improved integration of the CPG.  The EBP Project Team developed the sUTI protocol 
worksheet (Appendix J) and staff/provider education related to the protocol based on the 
systematic evaluation of gaps between current center practices and comparison to the 
AMDA CPG: CI.  A PowerPoint presentation (Appendix K) was utilized for 
staff/provider education in addition to return demonstration of technique for dipstick 
urine collection and performance, and role-playing of communication of protocol 
elements between staff and providers.  
       Implementation phase III. 
       The Project Leader in collaboration with the nursing leadership completed formal 
staff/provider education for the intervention including instructions for use of the sUTI 
worksheet.  The EBP Project protocol was piloted for a period of three months.  The 
sUTI Protocol binders with worksheets were placed in convenient locations in the nursing 
documentation area. The Project Leader made site visits to the center monthly during the 
pilot period and talked with individual and small groups of nursing staff regarding 
protocol utilization. Project Team members were present at monthly nursing staff 
meeting in the center and provided reminders for all staff regarding protocol utilization.  
Iowa Model Step 7: Evaluation of the Clinical Change 
       Selection of Outcomes and Methods. 
       Identification of outcome indicators is a critical step in a practice-based project. The 
outcome indicators for this project were derived from the overall project goal and 
purpose. Donabedian’s S-P-O Model was utilized as a framework for the evaluation 
components of the project. Donabedian (2005)) suggested that quality may be evaluated 




approaches: 1) structure of care, 2) process of care, or 3) outcome of care. For this 
project, assessment of the status of current structure indicators was completed as part of 
the project planning through assessment of administrative support and analysis of 
potential barriers and facilitators. The process and outcome approaches to evaluation 
utilized for the evaluation of this project are summarized and presented in Appendix G.  
        The outcome indicators included: 1) incidence of UTI per 1000 resident days and 2) 
incidence of unplanned discharges from the center to acute care facilities/emergency 
room for UTI/urosepsis per 1000 resident days, and 3) antibiotic usage. The Minimum 
Data Set (MDS) and patient charts were the sources of data for these outcome indicators.        
The process indicators of AMDA CPG: CI implementation were also evaluated and 
included: 1) evidence of process for suspected UTI risk, 2) evidence of suspected UTI 
assessment according to the AMDA CPG: CI, 3) evidence of appropriate diagnostics for 
suspected UTI according to the AMDA CPG: CI, 4) evidence that residents with 
suspected UTI being treated with antimicrobials therapy met criteria for UTI, 5) evidence 
that appropriate transmissions precautions were implemented for UTI caused by multiple 
drug resistant organisms (MDRO’s), and 6) staff evaluation of  process.  Staff evaluation 
of the process was evaluated through use of focus groups to identify staff perceptions of 
what went well, what could have been improved, and strategies for future improvements 
in regard to the project process.  Chart audits were the primary source of data for the 
remaining process indicators.  
      Measurement and evaluation of the quality of health is a complex process.  The 
evidence supports that infections, including UTI’s, in LTC residents predispose to serious 




(Engelhart, et al. 2005; Mylotte, 2005). These factors made the outcome and process 
indicators of the  project pertinent to the attainment of the project overall goal of 
improving quality of care for residents of a LTC center through best practices in UTI 
prevention and management and were  critical indicators of project success.         
        The outcome indicators of incidence of UTI per 1000 resident days, number of 
unplanned discharges to acute care/ER for UTI/urosepsis, and antibiotic usage were 
collected from the MDS and resident charts at both pre-intervention for baseline data and 
post-intervention for evaluation data. The process indicators of: 1) evidence of process of 
suspected UTI risk, 2) evidence of suspected UTI assessment in compliance with the 
AMDA CPG: CI, 3) evidence of appropriate diagnostics for suspected UTI in compliance 
with the AMDA CPG: CI, 4) evidence that residents with suspected UTI being treated 
with antimicrobial therapy meet criteria for UTI, and 5) evidence that appropriate 
transmission precautions are implemented for UTI caused by MDRO’s were evaluated 
through the post-intervention chart audit with the audit tool based on the AMDA CPG: 
CI(Appendix I). Appendix G outlines the evaluation components and measures utilized in 
the project.  
Cost Considerations  
        Infections are a significant source of morbidity and mortality in the LTC setting 
(Tsan et al., 2010).  The infection rates for patients in LTC ranges from 1.8-13.5 
infections per 1,000 resident-care days (Smith et al., 2008).  Infections are the reason for 
nearly half of all unplanned discharges from LTC facilities to acute care and result in an 
estimated financial burden to the nation’s healthcare system of as much as $2 billion 




therapy for infection in LTC are as high as $137 million annually (Smith et al., 2008) and 
account for up to 60% of systemic antimicrobials prescribed in the LTC setting (Nicolle, 
2001).   This has significant implications for the potential for widespread antimicrobial 
use and the contribution to antimicrobial resistance (Van Buul et al., 2012). 
      The cost considerations specific to this project included the material expenses 
associated with development time and production of written education materials and 
tools, which are presented in Table 3. There were no capital expenses incurred. There 
was no cost to the participants. The project team activities were implemented as part of 
the existing Quality Committee activities within the center. Therefore, additional 
compensation outside of that routinely expected from team members, as Quality 
Committee members were not required. The center administration supported project team 
activities by allotting time from regular scheduled work hours to be utilized for the 
project team activities by salaried employees who were project team members.  
 Table 3: Project-related Costs 
Project-related Costs  $$Amount 
Material Expenses  
• Paper and ink for fliers and project introduction materials for 
stakeholders, and chart audit tools(4 reams @ $6.79/ream and  
2 ink cartridges @ $25.09each)  
$77.34 
• Paper for educational handouts, sign in sheets, and other printed 
materials 
(10 reams @ 6.79/ream) 
$67.90 
• Additional office supplies for folders, pens, markers- 
approximated costs 
$ 50.00 
Labor Expenses  
All project team member compensation to be covered by facility within 








Summary of Implementation Methods 
       In this section, the strategy for implementing the AMDA CPG:CI in the pilot center  
was described. The strategy involved systematic evaluation of center practices compared 
to the AMDA CPG: CI to determine gaps in practice, plan interventions to address those 
gaps, and finally to implement those interventions. This process led to the development 
of a nursing-driven protocol worksheet designed to facilitate integration of critical AMDA 
CPG: CI elements into center practices. The implementation process included 
interdisciplinary contributions, support, collaboration, and communication. The pan for 






       In this section, the outcomes of the clinical change project will be presented.  A 
description of the data collection, preparation, and entry processes utilized for evaluation 
of the clinical and process outcomes is included.  
Population 
        The population for this project consisted of all patients of a 98-bed dually 
Medicare/Medicaid certified, for-profit long-term care enter. Two primary care 
physicians and a physician assistant provide attending medical management of center 
patients. The majority of facility patients have Medicaid as a payor source although 
Medicare, private pay, and commercial insurance are also accepted. The facility has a 
frail, elderly population with a majority of long-stay (>30 days) patients. A representative 
sample of the patents in the center is provided (Table 4).  The project sample was a 
convenience sample of patients in the center over the six-month project pilot period.   
Patient charts were included in the project review for process indicators if during the 
review period they were: 1) diagnosed with a UTI, 2) had an antibiotic prescribed for a 
UTI, or 3) had urinalysis/culture performed.  The total number of patient charts reviewed 




Table 4: Characteristics of a Representative Sample at the Nursing Center 
Number of Patients N= 89 
Average age (years) 76 
Females 77% 
Males 23% 
Payor Source  
    Medicare 10% 
     Medicaid 55% 
    Commercial 19% 
    Self/private pay 17% 
 
Reliability 
        The forms used for this project were developed by the DNP student who was also 
the Project Leader, based on current and relevant research and with the approval of the 
Medical Director of the center who is an expert in long-term care medicine. The Project 
Leader provided all education for this project and collected and recorded all data. This 
added to the consistency with which the education occurred and with which the process 
and outcomes were evaluated both of which enhanced reliability.  
Project Measures and Results 
        Data collected is presented in the sUTI project measures and outcome indicators 
tables (Table 5 and Table 6). The data collected reflects both clinical outcome indicators 
and process indicators. For the outcome indicators, incidence rates per 1000 resident days 
were calculated and for the process indicator, percentages were calculated. Incidence 
rates per 1000 resident days were calculated using this formula: number of infections per 
month/average monthly resident care days x 1000. The average monthly resident care 






Table 5: sUTI Project Measures and Outcome Indicators 
 
A chi-square test was used to test the rate difference between the pre-intervention and 
intervention incidence of UTI per 1000 resident days.  The pre-intervention period 
incidence rate of UTI was 5.4, whereas incidence rate in the intervention period was 3.5. 
The rate difference was 2.0 and it was not significant (χ2(1) = 1.28, p = 0.258).   A chi-
square test was also used to test the difference in the incidence rate of patients prescribed 
antibiotics in the center during the pre-intervention and intervention periods. In the pre-
intervention the incidence rate of antibiotic usage per 1000 resident days was 13.9, 
whereas the incidence rate was 10.7 during the intervention period. There was a non-
significant decrease of 3.2 (χ2(1) = 1.23, p = 0.268). To test the incidence rate difference 
between pre-intervention and intervention periods number of unplanned discharges, a 
Fisher’s exact test was used because the number of unplanned discharges in both pre-
intervention and intervention periods was <10. The incidence rate of unplanned 
discharges for the pre-intervention period were 0.3 and for the intervention period were 0, 
the rate difference of -0.3 was  not statistically significant (p = 1.000).     
 






Incidence of UTI per 
1000 resident days 
5.4 3.5 -2.0 
Incidence of unplanned 
discharges from the 
center to acute care  
facilities/ER for 
UTI/urosepsis per 1000 
resident days 
0.3 0 -0.3 
Incidence of antibiotic 
usage in Center per 
1000 resident days 




Table 6:  Project Measures and Process Indicators 







Evidence of process 
for sUTI risk 
24.49% 61.29% 36.80% 
sUTI assessment 
present 
22.45% 51.61% 29.16% 
Diagnostics for sUTI 
in compliance with 
CPG 
14.29% 54.84% 40.55% 
Patients with sUTI 
being treated with 
antimicrobial therapy 
meet criteria for UTI 





100% 100%  
        
        Chi-square and Fisher’s exact tests (depending on the sample size) were used to test 
the proportion difference between the pre-intervention and intervention periods 
occurrence of specific process indicators in patient records.  A chi-square test was used to 
compare the proportion of the process indicator of the evidence of process for sUTI risk 
between the pre-intervention and intervention periods. During the pre-intervention 
period, the measure for this indicator was 24.49% which increased to 61.29% during the 
intervention period, there was a significant 36.80% increase (χ2(1) = 10.83, p= 0.001). A 
chi square was also utilized to test the proportion difference between the pre-intervention 
and intervention periods of the process indicator of sUTI assessment. The process 
indicator of sUTI assessment documented for pre-intervention period was 22.45%, this 
number increased to 51.61% in the intervention period. The increase of 29.16% was 
significant (χ2(1) = 7.22, p=0.007).  For the process indicator of diagnostics for sUTI in 




since the number of patients with this indicator was <10 in the pre-intervention period. 
The measure of this indicator during the pre-intervention period was 14.29% while the 
intervention period measure was 54.84%. The 40.55% increase was significant (p < 
0.001).  For the process indicator for those patients being treated with antimicrobial 
therapy meeting the CPG criteria for UTI, the pre-intervention measure was 22.45% 
whereas, the intervention period measure was 61.29%, a chi-square test was utilized to 
test the difference and resulted in a significant 38.84% increase (χ2(1) = 12.22, p < 
0.001).  The final process indicator of appropriate transmission precautions being utilized 
for UTI caused by MDRO’s was not subjected to statistical analysis as both pre-
intervention and intervention period measures were 100%.   
       In addition to the process indicator measures, the process of the implementation of 
the project was evaluated through the use of focus groups. Three focus group sessions 
were held during the project (once monthly during the intervention period). These focus 
groups involved nursing staff, were informal and consisted of three questions: 
1. What is going well with the project? 
2. What are the challenges of the project? 
3. What changes do you think should be made to the project? 
Each focus group session lasted approximately 15 minutes.  Results from these focus 
groups included that overall, staff felt the project was going well, that the project goals 
were important to quality of care, and that the protocol was easy to understand and 
implement. The perceived challenges of the project related mainly to the time required to 
document. Suggestions for improvements included project tools that were displayed more 




Medicare charting flowsheet.  Table 7 displays the full results of the outcome measures 
and statistical tests for the project including differences and confidence intervals for each 
outcome. 





Intervention Post – Pre Chi-Square Test 




UTI per 1000 
resident days 
5.4 3.5 -2.0 -5.4 1.4 1.28 0.258 
# of unplanned 
discharges  
0.3 0.0 -0.3 -1.0 0.3  *1.00 
# of patients 
prescribed an 
antibiotic 








22.45% 51.61% 29.16% 8.05% 50.28% 7.22 0.007 
Diagnostics 
for sUTI in 
compliance 
with CPG 














100% 100%      







       The results for the project process indicators support the use of education and the 
sUTI protocol as an effective intervention to improve compliance with CPG 
recommendation related to to sUTI recognition and management in the LTC setting.  
There was statistically significance improvement in each of the process indicators 
supporting that there was a relevant clinical change that occurred as a result of the 
project.  
        For the outcome indicators of the project, the results were not statistically 
significant, but there is clinical significance in the reduction of the incidence of UTI per 
1000 resident days from 5.4% which was above the national benchmark of 5.3% 
(identified from the national MDS system) during the pre-intervention period to 3.5% 
which was below the national benchmark of 5.2% for the post-intervention period. This 
outcome is not only a project indicator but also a critical quality indicator for the center. 
Despite the lack of statistical significance of the reduction in incidence of UTI, the 
clinical implications from a quality of care perspective are significant.  Figure 2 displays 
the comparison of the baseline (pre-intervention) incidence of UTI to the 3-month 




Figure 2: Comparison of UTI Incidence per 1000 Resident Days to National Benchmarks 
 
        There are clinically significant implications related to cost savings that can be 
extrapolated from the project outcomes. There was the marked decrease in unplanned 
discharges related to UTI/urosepsis to zero. Although the statistical analysis did not show 
significance in this measure, the clinical significance is great when considering the 
potential impact on quality of life, morbidity and associated costs related to 
UTI/urospesis on the LTC patient population. The cost benefits of the project include a 
reduction in lost revenue from bed hold days required when Medicaid recipients 
experience an unplanned discharge to an acute care facility; the LTC center is reimbursed 
only a fraction of the daily rate when a patient is on a bed hold day. For example, a 
Medicaid patient for whom Medicaid is reimbursing the facility $164.80/day at the 
regular daily rate who is admitted to the hospital will have the room reimbursed at only 
$26.98/day.  The facility is required to bed hold these rooms for up to thirty days per year 



























urinalyses and cultures completed on those who do not meet criteria for UTI and 
subsequent costs associated with antimicrobial treatment for asymptomatic bacteriuria. 
There is also the potential for prevention/reduction of MDRO’s and Clostridium difficile 
gastroenteritis, which is associated with overuse of antimicrobials (Dellit, Owens, & 
McGowan, 2007).  
Consider the following case scenario: 
Anne Marie is a 74 year old white female residing in a long-term care facility. She 
has a medical history significant for moderate Alzheimer’s Dementia, hypertension, 
and diabetes mellitus type 2. Today, staff in the center has noted that Anne Marie is 
more irritable than usual and seems more confused. She denies any dysuria, or other 
urinary symptoms. She is afebrile and her vital signs are within normal parameters for 
her. The nurse believes that Anne Marie’s symptoms could indicate a UTI. She 
obtains a mid-stream urine specimen and sends it to the laboratory for analysis.  The 
initial urinalysis is leukocyte esterase negative but shows a few bacteria. The 
specimen has been sent for culture.  Three days later the culture results come back 
with >10,000 cfu’s of E.Coli.  In the meantime, Anne Marie was much better the day 
following the collection of her urinalysis and the nurse was notified by the oncoming 
evening shift that Anne Marie’s family had taken her to a family birthday party the 
evening before and that could have explained her behavior change.  Her attending 
physician is notified of the culture results and she is prescribed a seven-day course of 
levofloxacin 500 mg by mouth daily. Subsequently she develops diarrhea requiring 
her to wear adult incontinence pads to prevent soiling her clothing, which is 




activities for four days. She also develops incontinence dermatitis and requires one 
week of treatment with a zinc oxide cream to resolve.  
        This case illustrates a common occurrence in the LTC setting. A patient has a 
urinalysis obtained for non-specific symptoms and the subsequent culture reflects 
incidental asymptomatic bacteriuria. Although the patient is not symptomatic for a 
UTI, treatment is instituted based on culture results. The estimated costs for this 
uncomplicated UTI are presented in Table 4. In addition to the obvious monetary 
costs, the cost to the patient’s dignity related to the need for incontinence supplies and 
the discomfort associated with the diarrhea and related symptoms stand to 
significantly impact the patient’s quality of life.  
Table 8: Suspected UTI and Associated Costs 
Suspected UTI-related service/product $$ Cost 
Routine urinalysis with culture $98.00 
Levofloxacin 500 mg 7 day regimen $18.42 
Incontinence supplies (6 days) $80.00 
Additional staff time required for care of 
Incontinence and associated symptoms @ 
Additional .75 hr/8 hour shift x 3 shifts/day x 6 days x 
$9.60/hr 
$129.60 
Zinc oxide cream x 1 tube 
 
$5.50 






V. IMPLICATIONS AND RECCOMMENDATIONS 
       This evidence-based clinical change project addressed the clinical problem trigger of 
increased rates of urinary tract infections in a rural southwestern Ohio nursing center. The 
clinical change involved the systematic implementation of the American Medical 
Director’s Association (AMDA) Clinical practice Guideline for Common Infections into 
the center.  An interdisciplinary team approach to evidence-based clinical change was 
utilized through use of the IOWA model of evidence-based practice.  The significant 
implications for this project include support for the use of a nursing-driven, evidence-
based protocol to facilitate systematic implementation of CPG’s in the LTC setting and 
evidence to support the efficacy of the AMDA CPG: CI guideline for reduction of UTI 
rates and antimicrobial usage in the LTC setting.  
Strengths and Limitations 
        The strengths of this project included the involvement of the stakeholders 
(providers, nurses, administration, and nursing leadership) who were able to provide 
input, knowledge, and support for the project.  This project represented the first evidence-
based team project in the center and process evaluation indicated that this approach is 
well received by staff which paves the way for future projects in the center. This project 
is one of very few available examples of systematic evaluation and integration of a CPG 
in the LTC setting.  
         Limitations of the project included the convenience sample, the relatively short 
project time period of three months and the resulting lack of ability to establish statistical 
significance for project outcomes. Another limitation inherent to the process of this 




in the center are ongoing and the census is not static, but rather subject to daily changes 
in patient mix, which means that, a variety of uncontrolled variables could also be 
potentially impacting outcomes.  
Recommendations 
        This clinical change project was an important step toward measuring the impact and 
evaluating the process of systematic implementation of CPG’s to reduce UTI and 
improve UTI management in this rural southwestern Ohio LTC setting.  The findings of 
this project determined a marked improvement in compliance with critical elements of 
the AMDA CPG: CI through use of a nursing-driven, evidence-based protocol. There was 
an also clinically significant reduction in the overall incidence of UTI, antimicrobial 
usage, and unplanned discharges related to URI/urosepsis.  Recommendations for future 
EBP application include: 
• Implementation in LTC centers that are in a variety of geographical locations to 
determine the applicability to a variety of settings.  
• Measure of outcomes across a greater duration of time to gauge impact across time 
and sustainability of interventions.  
• Development of additional tools for staff to use as reference for following AMDA 
CPG: CI recommendations (i.e. poster with charting elements and criteria).  
Summary 
        The project had a clinical problem trigger of UTI incidence greater than the national 
benchmark and increased unplanned discharges related to UTI/urosepsis.  The overall 
project goal was to improve the quality of care of LTC residents through use of best 




Practice was used to guide the project. Through an interdisciplinary team approach to 
EBP. An assessment of internal and external data led to the identification of the PICOT 
question: In patients living in a LTC facility (P), how does implementation of the AMDA 
Clinical Guideline: Common Infections (AMDA CPG: CI) (I) compared to current 
practices(C) affect urinary tract infection rates, antimicrobial usage, unplanned 
discharges (O) over three months (T).   
        A systematic evaluation of current center practice compared to the AMDA CPG: CI 
recommendations led to the project team development of a nursing-driven protocol for 
sUTI recognition and management as an intervention to close the gaps between current 
practice and best practice as defines by the CPG.  The protocol was implemented in the 
center and both outcome and process indicators were measured and analyzed. Incidence 
of UTI, antimicrobial use, and unplanned discharges were reduced during the 
intervention period though these were not statistically significant upon computation. 
Process indicators supporting the evidence of compliance with AMDA CPG:CI 
recommendations  were also improved and these were statistically significant.  
        Dissemination of the project results is an important step in advancing future CPG 
integration and evaluation in the LTC setting and is critical in promoting the clinical 
practice doctorate in nursing (Melnyk & Fineout-Overholt, 2011).  Abstracts for this 
project have been submitted to the national Geriatric Advanced Practice Nurses’ 
Association (GAPNA) and the national DNP conference in 2015. A manuscript for 
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Identified Barriers and Facilitators for EBP Change Project 
Barriers Action Plan 
Need for staff/team buy-in and accountability 
for utilizing  EBP project process 
 
 
Met with key stakeholders and discussed 
proposed EBP Clinical Change Project in 
relationship to quality, cost, and outcomes 
Acceptance of EBP project process by medical 
providers in the center 
 
Worked through center Medical Director to 
encourage acceptance and participation 
 
Lack of history of  culture of support for EBP 
within the center 
 
Introduced EBP principles to the 
Interdisciplinary Project Team and educated all 
clinical staff on the project  and basic EBP 
principles 
Sustainability of the CPG across shifts and 
over time 
 
Targeted educational intervention to promote  
compliance with the CPG 
Historical limited engagement by professional 
pharmacy and medical professionals in 
quality improvement activities in the center.  
APRN met individually with pharmacy 
consultant and medical providers to provide 
information about the project and gain buy-in 
and commitment for participation 
Facilitators Action Plan 
Currently established support from the center 
Administrator, nursing leadership and 
Medical Director with the clinical problem 
identified as an organizational priority 
 
Continuous communication and update on 
project implementation schedule 
Administrator support for compensation of 




Provided cost-benefit analysis to center 
Administrator to provide support for rationale 
of compensation for project time 
Administrator communicated her support of 
the project to staff 
 
Medical director is familiar with AMDA 
guidelines, is an active MADA member and 
has expressed support for use of the AMDA 
CPG: CI  
Continuous communication and update on 
project implementation schedule 
Medical director communicated his support of 










Keyword(s) used Database/Source 
used 
# of Hits Listed # of Hits 
Reviewed 
# of Hits 
Used 
2/3/12 UTI CINAHL 834   
2/3/12 UTI or Urinary Tract 
Infection AND long term 
care 
CINAHL 876   
2/3/12 UTI  OR Urinary Tract 
Infection AND LTC OR 
Long Term Care 
CINAHL 2157   
2/3/12 UTI  OR Urinary Tract 
Infection AND LTC OR 
Long Term Care Plus 
limits of EBP and 
English articles only 
CINAHL 62 62 2 
9/12/13 UTI  OR Urinary Tract 
Infection AND LTC OR 
Long Term Care Plus 
limits of EBP and 
English articles only plus 
date range 2012-2013 
CINAHL 15 15 3 
2/3/12 Clinical Practice 
Guidelines AND long 
term care 
CINAHL 9 9 6 
9/12/13 Clinical Practice 
Guidelines AND long 
term care plus date range 
2012-2013 
CINAHL 10 10 1 
2/3/12 UTI PubMed(Medline) 8809   
2/3/12 Urinary Tract Infection PubMed(Medline) 28,891   
2/3/12 UTI or Urinary Tract 
Infection 
PubMed(Medline) 32,938   
2/3/12 UTI or Urinary Tract 




PubMed(Medline) 28,918   
2/3/12 UTI or Urinary Tract 
Infection AND long term 
care OR LTC with limits 
of: human, age 19+ years, 
date range 1/01/2000- 
12/31/2012, clinical 
trials, meta-analysis, rct, 
practice guideline, 
English, PLUS EBM 























9/26/13 UTI or Urinary Tract 
Infection AND long term 
care OR LTC with limits 
of: human, age 19+ years, 
date range 12/31/2012- 
9/26/2013, clinical trials, 
meta-analysis, rct, 
practice guideline, 
English, PLUS EBM 
PubMed(Medline) 0 0 0 
2/3/12 Clinical Practice 
Guidelines AND Urinary 
Tract Infections with 
limits of: humans, aged 
65+ years, English 
 
PubMed(Medline) 47 47 2(same 2 
as in 
CINAHL) 
9/26/13 Clinical Practice 
Guidelines AND Urinary 
Tract Infections with 
limits of: humans, aged 
65+ years, English 
 
PubMed(Medline) 1 1 0 
9/26/13 Urinary Tract 
Infection(keyword) and 
older adults or long term 
care 






Evidence Included and Excluded with Rationale 
 
Citation 





Hooton, T. et al. Clinical 
Infectious Diseases, 50, 
625-663 (2010) 
Diagnosis, prevention, and 
treatment of catheter-
associated urinary tract 
infection in adults: 2009 
international clinical 
practice guidelines from the 
Infectious Diseases Society 
of America 
Included- CPG related to 
CAUTI with specific 
considerations for LTC 
included. This CPG is 
included in the AMDA CPG: 
CI. 
Gould, C. et al. HICPAC 
(2010) 
Guidelines for prevention 
of catheter-associated 
urinary tract infections 
2009 
Included- CPG for CAUTI 
with comprehensive grading 
of evidence for each 
intervention. This CPG is not 
included in AMDA CPG: CI 
due to its release in late 
2010. 
Smith, et al. American 




Infection prevention and 
control in the long term 
care facility 
Included- general CPG for 
infection prevention in LTC, 
includes recommendations 
for UTI prevention. This 
CPG is included in AMDA 
CPG: CI. 
Deuster, S. et al. Journal 
of Clinical Pharmacy and 
Therapeutics, 35, 71-78. 
(2010) 
Implementation of 
treatment guidelines to 
support judicious use of 
antibiotic therapy 
Include- Intervention study 
on education on treatment 
guideline for UTI. 
Genao, L. et al. Annals of 
Long Term Care, 20(4), 
33-38.  
Implementation of a UTI 
algorithm to reduce 
inappropriate antibiotic 






Include-Intervention study on 
implementing clinical 
guidelines in LTC 
Citation 





Woodford, H. Journal of 
the American Geriatric 
Society, 57, 107-114. 
(2009) 
Diagnosis and management 
of urinary tract infection in 
hospitalized older people 





Juthani-Mehta, M., et al.  
Journal of the American 
Geriatric Society, 57, 963-
970. (2010) 
Clinical features to identify 
urinary tract infection in 
nursing home residents:  A 
cohort study 
Included- this is a study that 
supports the use clinical 
criteria for accurate UTI 
diagnosis. 
Colon-Emeric, C. Journal 
of the American Geriatrics 
Society, 55, 1404-1409. 
(2007) 
Barriers to and facilitators 
of clinical practice 
guideline use in nursing 
homes 
Included- addresses potential 
barriers and suggestions for 
implementation of CPG 
Resnick, B., et al. Journal 
of the American medical 
Directors Association, 
Jan-Feb, 1-8. (2004) 
Testing the feasibility of 
implementation of clinical 
practice guidelines in long 
term care facilities 
Included- provides qualitative 
data regarding 
implementation of CPG in 
LTC. 
Wipke-Tevis, et al. 
Jouranl of the American 
Geriatric Society, 52, 583-
588. (2004) 
Nursing home quality and 
pressure ulcer prevention 
and management practices 
Included- Provides a basis for 
developing educational and 
quality improvement 
programs related to use of 
CPG and quality in LTC. 
Hutt, E, et al. Journal of 
the American geriatric 
Society, 54, 1694-1700. 
(2006) 
A multifaceted intervention 
to implement guidelines 
improved treatment of 
nursing home acquired 
pneumonia in a state 
veteran’s home.  
Included- Demonstrates 
effectiveness of evidence-
based guidelines in 
improving compliance with 
current practice standards. 
Berlowitz, D. et al. 
American Journal of 
Medical Quality, 16, 189-
195. 
Clinical practice guidelines 
in the nursing home.  
Included- Supports that 
CPG’s are not systematically 
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Synthesis of CPG in LTC Evidence 
 
Study Design Sample Outcome 
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Evaluation Component Measurement Approach 
Outcome Indicators  
        Incidence of UTI per 1000 resident      
        days 
System data for facility size and census 
        Incidence of unplanned discharges  
        from the center to acute care  
        facilities/ER for UTI/urosepsis  
System data for facility size and census 
        Incidence of antibiotic usage in    
        center 
System data from monthly pharmacy 
report and retrospective chart audits 
Process Indicators  
        Evidence of process for suspected UTI 
        risk 
Included in the chart audit tool (developed 
by project team) 
        Evidence of suspected UTI assess- 
        ment in compliance with AMDA CPG: 
        CI 
Records reviewed for pre-intervention and 
post-intervention (3month interval) using 
chart audit tool. 
        Evidence of appropriate diagnostics  
        for suspected UTI in compliance with 
        AMDA CPG:CI 
Records reviewed for pre-intervention and 
post-intervention (3month interval) using 
chart audit tool 
        Evidence that residents with  
        suspected UTI being treated with 
        antimicrobial therapy meet criteria 
        for UTI 
Records reviewed for pre-intervention and 
post-intervention (3month interval) using 
chart audit tool 
        Evidence that appropriate  
        transmission precautions are  
        implemented for UTI caused by  
        MDRO’s.  
Records reviewed for pre-intervention and 
post-intervention (3month interval) using 
chart audit tool 






EBP Project Implementation and Evaluation Timeline 
 
Activity Timeline 
Step  1: Selection of a Topic  
• Identification of problem trigger: Increased UTI and associated negative 
patient outcomes 
• Identify Stakeholders 
• Identify barriers and facilitators and strategies for minimizing barriers 
and maximizing facilitators 
Completed 
December 2011 
Step 2: Form a Team  
• Determine team members and team roles 




Step 3: Evidence Retrieval   






September 2013.  
Step 4: Grading the Evidence  
• Complete appraisal of evidence 







Step 5: Developing an Evidence-based Standard/Recommendation  
• Define project purpose 
• Define project outcome indicators of a successful project. 
• Develop data collection protocol  
• Develop process evaluation tool(s) 
• Develop project-related products 
• Develop evaluation plan 
• Develop project economic analysis 
• Complete presentation for dissemination of project initiation and educate 
stakeholders on project progress to date 
• Complete project proposal draft in NURS 7090 
• Begin acquisition of necessary approvals (facility approval, IRB) 
 
December 2013 
• Revise project proposal and share with Project Chair January-February, 
2014 




• Finalize project proposal 
• Finalize necessary IRB approval and submit when committee approval 
received 
March-April, 2014 
Step 6: Implementing the EBP Project   
Phase I: Timeline and Baseline Data Collection  
• Meet with team and discuss project timeline and inform stakeholders of 
implementation date 
- Develop formal schedule for implementation 
July 2014 
• Complete baseline data collection of outcome indicators  September 2014 
• Complete process indicator evaluation 
- This will be based on the AMDA CPG: CI and will involve a systematic 
assessment of current practices in the center as they compare to the 
CPG 
- Complete baseline staff knowledge survey 
September 2014 
Phase II: Design Clinical Change Intervention(s)  
• Team will review baseline data and determine intervention where gaps 
between practice and CPG exist. 
• Intervention(s) will be planned based on this assessment 
• This will include development of additional project products required for 
the intervention(s) implementation and evaluation. 
• Determine the “go live” date for intervention implementation  
 
September 2014 
Phase III: Deploy Clinical Change Intervention(s)  
• Complete formal education session(s) for intervention(s); this will 
include instructions for use of any project products necessary for 
intervention implementation 
September 2014 
• “Go Live” October 2014 
Step  7: Evaluation of the Clinical Change  
• Complete outcome indicator evaluation 
- Monitor incidence of UTI per 1000 resident days over 3 month period 
following “go live” date 
- Monitor incidence of unplanned discharges to acute care/ER for 
diagnosis UTI/urospesis over 3 month period following ‘go live “ date 





• Complete process indicator evaluation 
-      Evidence of process for suspected UTI risk 
               -      Evidence of suspected UTI assessment in compliance CPG 
- Evidence of appropriate diagnostics for suspected UTI in compliance 
with AMDA CPG: CI 
- Evidence that residents with suspected UTI being treated with 
                      antimicrobial therapy meet criteria for UTI 
- Evidence that appropriate transmission precautions are         
implemented for UTI caused by MDRO’s 
- Complete focus groups with nursing staff 
 
February 2015 





Suspected Urinary Tract Infection Chart Audit Guidelines 
Background 
Infections are common in Long Term Care (LTC), represent a major source of morbidity and 
mortality in LTC, and contribute significantly to unplanned discharges from LTC to acute 
care settings. Urinary tract infections (UTI) are one of the most common infections in LTC 
facilities.  
Measure 
This audit will determine the number of residents with suspected or diagnosed UTI in the 
LTC facility who met the American Medical Director’s Association (AMDA) clinical practice 
guideline (CPG) for common infections in LTC standards. 
Instructions 
This CPG-specific chart audit tool is derived from the AMDA CPG: Common Infections and 
focuses on those aspects of the practice guideline pertaining to UTI.  This tool is used to 
document the review of source documents and CPG for agreement.  Source documents are 
original documents/data/records (i.e. clinic charts/notes, checklists, lab reports, diagnostic 
reports, etc.). 
For each subject reviewed: 
1. Begin using this tool by completing the header information (name of site, name of 
reviewer, date of review, review period).  
2. For each section reviewed, check the appropriate boxes (‘N/A’, ‘Yes’, ‘No’).  If the 
‘No’ box is checked for any question, provide a description for each ‘No’ response in 
the area provided within that section. 
3. At the conclusion of the review, summarize findings in the Summary of Findings 
section.   
4. The reviewer signs and dates the Chart Audit Tool and files it within the UTI Chart 
Audit binder. 
Reference 
American Medical Director’s Association (2011). Common infections in the long-term care 





Suspected UTI Chart Audit Tool 
 
Site:____________________________________Review Date:_____________________ 
Reviewed by:____________________________Review Period:____________________ 
Inclusion Criteria: (please check appropriate box) 
  Diagnosis of UTI during review period 
  Antibiotic prescribed for UTI during review period 
  Urinalysis/urine culture performed during review period 
         

















Suspected UTI Chart Audit Tool 
Site:____________________________________Review Date:____________________ Review 
Period:__________________________________________________________ 
Reviewed by: ____________________________________________________________ 
Element A: Recognition Yes No n/a Comments 
1. Presence of dysuria OR two (2) or more of 
the following documented (Check those 
that are documented). 
  Fever(100 degrees F or 2.4 degrees 
above baseline) 
  Urinary frequency  
  Urinary urgency 
  Flank /suprapubic pain 
  Gross hematuria 
  New or worsened urinary 
incontinence 
  Shaking chills/rigors 
  New onset of delirium 
    
 
Element B: Assessment Yes No n/a Comments 
2. Documentation of nursing history and 
physical exam elements present at the 
time of initial symptom(s)? 
    
Physical assessment including body 
temperature 
    
Dipstick urine test results documented     
Medical provider notified of resident 
condition and symptoms 
    
Urinalysis ordered      




    
3. MDRO identified as causative organism by 
culture? 
    
4. If answer to item 3 was “yes”: 
Evidence of contact transmission 
precautions order present? 
    
5. Patient transferred to an acute care 
setting? 
    




Evidence of at least one (1) of the following 
are present in the record: Check those that 
are documented as present.  
  Resident’s vital signs unstable and/or 
family /patient requests transfer or 
desire aggressive treatment.  
  Critical diagnostic tests are not 
available in the facility during the 
required time period.  
  Scope or intensity of required 
monitoring or treatment is beyond 
facility’s capacity.  
  Specific infection prevention/control 
measures are not available in the 
facility.  
7. Evidence of ongoing monitoring 
documented in the chart in regard to 
resident response to treatment? (i.e. body 
temperature, presence of  clinical s/s 
infection) 
    
 
Element C: Treatment Yes No n/a Comment
s 
1. Antipyretic administered for fever greater 
than 100 degrees F?  
    
2. Antibiotic therapy prescribed before urine 
culture results were available?  
Antibiotic 
prescribed:______________________________ 
(please provide full Rx. Info including 
drug, dose, route, frequency, and duration) 
    
3. Urine culture negative?     
4. If answer to item 10 was “yes” was 
antibiotic therapy discontinued? 
    
5. Antibiotic therapy prescribed based on 
urine culture results? 
Antibiotic 
prescribed:______________________________ 
(please provide full Rx. Info including 
drug, dose, route, frequency, and duration) 
    
6. Antibiotic change indicated based on urine 
culture results? 
    
7. If answer to item 13 was “yes”, was a 
change in antibiotic regime implemented? 





Does the resident have any of the following? (Check  those that apply) 
 __________Intermittent bladder catheterization 
 __________Indwelling foley catheter 
 __________Supra-pubic catheter 
 __________Ileoconduit device 











Signature of Reviewer:___________________________________Date:______________ 
Reference 
American Medical Director’s Association (2011). Common infections in the long-term care 






Suspected Urinary Tract Infection (SUTI) Protocol Worksheet 
Patient Name:__________________________ 
Step 1: Does the patient have a change in condition that suggests UTI? 
The patient has had a change in: (Please circle all that apply) 
o Vital signs: Temp, Resp rate, Pulse, BP 
o ADL performance 
o Food/fluid intake 
o Mental status 
o Skin temperature/color 





o Urinary frequency 




Step 2: Perform History and Physical Exam 
• Vital Signs__________T_____________P_____________R________________BP 
• Mental Status: __Alert___Lethargic___Confused___Other:_________________________________ 
• FSBS if patient is diabetic:______________ 
• Urinary Symptoms: ____dysuria______hematuria____ suprapubic/flank pain 
        _____ scrotal contents tenderness_____ bladder distention_____________other(please specify) 
Obtain a urine specimen and perform dipstick urine test and record: 
       Date:___________Time:__________ 
       Results: ___ Positive for leukocyte esterase/WBC (Send specimen for UA/C&S) 
                     ___ Negative for leukocyte esterase/WBC (Consult  physician/PA/NP) 
Determine if patient meets criteria for empiric antibiotic therapy: 
• Patients WITHOUT indwelling catheter (Must have at least 3) 
• Patients WITH indwelling catheter (Must have at least 2 ) 
 Fever greater than 100 F or chills/rigors 
 New or increased dysuria, frequency, or urgency 
 New flank/suprapubic pain/tenderness 
 Change in character of urine  
 Worsening mental or functional status (includes urinary 
incontinence) 
               Does the patient meet criteria for empiric antibiotic therapy? 




                                ____No -  proceed to Step 3 and anticipate ongoing infection surveillance                                                                                                                         
 
 
                                                                                 Nurse Initials:_________ Date:_________Time:__________                                          
Step 3: Notification of Provider 
Date:_______Time:________Provider:_______________ 
Patient condition warrants transfer to acute care?____Yes (Contact Physician/PA/NP) ____No  
Further diagnostics ordered?___No___Yes:________________________________________________ 
Antibiotic therapy ordered?____No____Yes 
* Communicate whether patient meets criteria for empiric antibiotic therapy  
 
                                                                                           Nurse Initials:_________ Date:_________Time:__________                      
 
Step 4: Treat Symptoms of SUTI 
• Encourage fluid intake (target goal of 1500 ml over next 24 hours unless contraindicated) 
• Treat fever if it is: 
a) Causing discomfort 
b) Resulting in S/S of hemodynamic instability (pulse > 100 bpm, hypotension) 
 
Step 5: Develop Individual Acute Care Plan 
• Communicate to care team members 
                                                                                    Nurse Initials:_________ Date:_________Time:__________     
Step 6: Monitor Patient Response 
• Assess and document every shift to include exam elements in Step 2 
• Assess and document every shift response to treatment  
• Report any deterioration or failure to respond to treatment to provider 
• Communicate UA/urine culture results to provider 
 
Step 7: Determine if Heighted Infection Control is Warranted 
Urine culture results:_____________________________________________________ 
Is the causative agent identified by culture as a multi-drug resistant organism (MDRO)? 
___No- Standard precautions 
• Urine must be contained by patient continence, incontinence supplies, or catheter 
 
___Yes- Contact Precautions  
• Urine must be contained by patient continence, incontinence supplies, or catheter 
• Order for Contact Precautions is written and implemented as appropriate        
                                                                             Nurse Initials:_________ Date:_________Time:__________ 
 
Step 8: Communication 
Communicate the following to the care team: 
• Patient status 
• Any heightened Infection Control  
 
Please place the SUTI Protocol Worksheet in the protocol binder once the culture report has been 








American Medical Directors Association (AMDA) (2011). Common Infections in the  
        Long term Care Setting Clinical Practice Guideline. Columbia, MD: AMDA  
       2011. 
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Appendix  K 
PowerPoint for sUTI Protocol Education 
Slide 1 
Suspected Urinary Tract Infection 
(SUTI) Protocol




Infections in Long Term Care (LTC)
 Infections are a significant source of illness and death in 
LTC.
 Infections account for ½ of all transfers to acute care 
facilities from LTC










 The SUTI protocol has been developed by an 
interdisciplinary team to address the gaps between 
current facility practice and best practice. 
 The American Medical Directors Association Clinical 
Practice Guideline for Common Infection in LTC  and HCF 
Infection Control policies have been used to create the 
protocol. 





 Reduce the incidence of UTI and urosepsis
 Reduce incidence of MDRO UTI
 Reduce unplanned discharges related to UTI
 Reduce antibiotic usage for asymptomatic bacteriuria
 




Step 1: Does the patient have a 


























Full Worksheet will be distributed and 





 This is a quick and efficient way to SCREEN for SUTI




 If a dipstick urine is positive, and
the patient has symptoms of SUTI
send the specimen to the 
lab for UA/C&S
 
Will do demonstration/return demo of 













To treat(empirically) or not to treat?
 Patients WITHOUT indwelling 
catheter must have 3
 Patients With indwelling 
catheter must have 2
 Fever greater than 100 F 
OR  chills/rigors




 Change in character of 
urine
 Worsening mental or 
functional status (includes 
urinary incontinence)
 
Discuss role of nursing in assisting 









Step 3: Notification of Provider
 Does the patient’s condition warrant transfer to acute 
care? 
 The patient has unstable vital signs and the patient/family  
desire aggressive intervention
 Required diagnostics are not available in an appropriate 
time period
 The scope or intensity of monitoring are beyond the facility’s 
capacity
 Patient/family request a transfer
* The physician/PA/NP  must be notified of any impending 








Assisting the provider to make an 
informed treatment decision
 Provide a clear, concise picture of the patient condition
 Communicate whether the patient meets criteria for 
empiric SUTI treatment or not
 
Discuss the evidence concerning 
treatment of AB and infection 
surveillance while awaiting culture 
(many patients improve in this time).  








Step 4: Treat Symptoms of SUTI
 Encourage fluid intake
 Target goal = 1500 ml over 24 hours unless contraindicated
 Treat fever if:
 It is causing discomfort
 There is hemodynamic instability
 Pulse >100 bpm
 hypotension
 


























Step 6: Monitor Response
 Assessment and documentation every shift to include exam 
elements in Step 2
 Assessment and documentation of response to treatment 
(as appropriate)
 Report any deterioration or failure to respond to treatment 
to provider (refer to Change in Condition Tool to determine 
whether immediate vs. non-immediate notification is 
appropriate)
 Communicate results of UA/C&S to provider 
 If the culture is negative, any empiric 




Step 7: Determine if Heightened 
Infection Control is Warranted
 Standard Precautions are applied to all patients at all 
times
 Standard Precautions are acceptable for MOST SUTI’s
 Contact Precautions may be necessary if the causative 
organism is a MDRO
 Urine must be contained by patient continence, 
incontinence supplies, or catheter














 Communicate the following to the care team:
 Patient status









 Mrs. P is an 81 year old patient who was admitted 3 days 
ago following a fall at home. She had no fractures but 
multiple contusions and was in the hospital for 24 hours 
prior to her admission here for rehab. She has DM2 and 
OA. 
 During your morning med pass Mrs. P tells you that she 
has had some low back discomfort and feels nauseous 
today. She ate <25% of breakfast. Her STNA reports that 
she was incontinent of urine twice through the night 
though she has been continent until now. VS: T=99.1, 








 Your assessment reveals + suprapubic tenderness but no 
distention. Mrs. P tells you that she has had to urinate 4-5 
times this morning but “only go a little each time”.
 Dipstick urine is + for nitrites and leukocytes and urine is 
milky in appearance
 
Does Mrs. P likely has a UTI?  
Does she meet criteria for empiric 
therapy?  
 
You notify the physician and he orders 
Levaquin 500 mg once daily  x 7 days.  
The urine is sent for culture.  
After approx. 14 hours Mrs. P reports 
she is feeling better.  
The urine culture revelas >100,000 E. 






 Mrs. M is a 78 year old LTC patient at the center. She has 
mild to moderate Alzheimer’s dementia and HTN. Her 
daughter took her on an LOA to a family birthday party this 
afternoon. Upon returning with Mrs. M to the center, Mrs. M’s 
daughter reports that Mrs. M was confused and agitated 
and refused to eat or drink anything during the outing and 
she is concerned that something is wrong. 
 When you assess Mrs. M you find that she is alert, mildly 
agitated and more confused than her usual. VS: T= 97.4, R= 
16, P= 74, BP= 116/70. 
 The STNA toilets Mrs. M and reports that her urine is dark and 
strong-smelling. She had no complaints of additional urinary 
symptoms. 
 
What other assessment data might 
you collect?  
Could this patient have a SUTI?  
 
You decise to do watchful waiting for 
Mrs. M and encourage fluids  over the 
evening and re-evaluate her . At 
bedtime Mrs. .M.  Exhibits no 
agitation and  seems more like her 
usual. She is still afebrile and has no 
localizing urinary symptoms. The next 




An ounce of prevention……
 Encourage adequate hydration
 Monitor personal hygiene of patients
 Use of appropriate incontinence products
 Toileting program
 Avoid or limit bladder catheterization when possible
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